SMNR
Semnur Pharmaceuticals, Inc.Company Information
- Company Name
- Semnur Pharmaceuticals, Inc.
- CIK
- CIK0001913577
- Category
- Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
- Ticker: Exchange
- SMNR: OTC, SMNRW: OTC
- Fiscal Year End
- December 31
- Owner Organization
- 03 Life Sciences
- SIC
- 2834
- SIC Description
- Pharmaceutical Preparations
- Ticker
- SMNR
SEC filing data through
Insider Sentiment
- Last purchase
- —
- Last sale
- 2025-09-23
- Shares purchased (TTM)
- 0
- Shares sold (TTM)
- 554,849
Institutional Sentiment
- As of
- 2026-06-30
- Institutional shares owned
- 146
- Shares outstanding
- 230,209,142
- Ownership
- 0.00%
Earnings Market Reaction
- Filing date
- 2026-08-10
- Price on filing date
- —
- 1-month reaction
- -33.27%
- 3-month reaction
- …
Balance Sheet
Values in millions ($)| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Related Party | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
Assets Current | ||||||||||||||||||
| Cash And Cash Equivalents At Carrying Value | 0 | 0 | 0 | 0 | 0 | - | 0 | - | 0 | 0 | 0 | 0 | ||||||
| Prepaid Expense Current | 1 | 1 | 1 | 0 | 0 | - | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Other Assets Current | 0 | - | 0 | 0 | - | - | 6 | - | - | - | - | - | ||||||
| Assets Current | 1 | 1 | 1 | 0 | 0 | 0 | 6 | 0 | 0 | 0 | 0 | 0 | ||||||
Assets Noncurrent | ||||||||||||||||||
| Assets Held In Trust Noncurrent | - | - | - | - | 1 | 9 | 9 | 9 | 52 | 51 | 50 | 90 | ||||||
| Property Plant And Equipment Net | 1 | 1 | 1 | 1 | - | - | 1 | - | - | - | - | - | ||||||
| Assets | 2 | 2 | 1 | 1 | 1 | 9 | 7 | 9 | 52 | 51 | 51 | 90 | ||||||
Liabilities And Stockholders Equity | ||||||||||||||||||
| Accounts Payable And Other Accrued Liabilities Current | - | - | - | - | 5 | 5 | 5 | 4 | 4 | 4 | 4 | 4 | ||||||
Liabilities Current | ||||||||||||||||||
| Accounts Payable Current | 7 | 6 | 6 | 4 | - | - | 0 | - | - | - | - | - | ||||||
| Other Accrued Liabilities Current | - | - | 0 | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Other Notes Payable Current | - | - | - | - | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
| Accrued Liabilities Current | 2 | 1 | 1 | 1 | - | - | 0 | - | - | - | - | - | ||||||
| Notes Payable Current | 2 | 3 | 4 | 4 | - | - | 0 | - | - | - | - | - | ||||||
| Liabilities Current | 11 | 10 | 10 | 10 | 8 | 8 | 0 | 7 | 6 | 6 | 6 | 5 | ||||||
Liabilities Noncurrent | ||||||||||||||||||
| Liabilities | 32 | 27 | 22 | 15 | 11 | 11 | 49 | 9 | 9 | 9 | 8 | 8 | ||||||
| Temporary Equity Carrying Amount Attributable To Parent | - | - | - | - | 1 | 9 | 9 | 9 | 52 | 51 | 50 | 90 | ||||||
Stockholders Equity | ||||||||||||||||||
| Preferred Stock Value | 0 | 0 | 0 | 0 | - | - | 0 | - | - | - | - | - | ||||||
| Common Stock Value | 0 | 0 | 0 | 0 | - | - | 0 | - | - | - | - | - | ||||||
| Additional Paid In Capital | 255 | 255 | 255 | 255 | - | - | 73 | - | - | - | - | - | ||||||
| Retained Earnings Accumulated Deficit | -285 | -280 | -276 | -270 | -11 | -11 | -115 | -9 | -9 | -9 | -8 | -8 | ||||||
| Stockholders Equity | -30 | -25 | -21 | -15 | -44 | -43 | -43 | -42 | -9 | -9 | -8 | -8 | ||||||
| Liabilities And Stockholders Equity | 2 | 2 | 1 | 1 | 1 | 9 | 7 | 9 | 52 | 51 | 51 | 90 | ||||||
| Temporary Equity Shares Outstanding | - | - | - | - | - | - | - | - | 1 | - | - | - | ||||||
| Common Class A | - | - | - | - | 0 | 1 | 1 | 0 | 0 | 1 | 5 | 0 | ||||||
| Common Stock | - | - | - | - | - | - | - | - | - | 200 | - | - | ||||||
| Common Class B | - | - | - | - | 0 | 2 | 0 | -2 | 0 | 2 | 0 | 0 | ||||||
| Cash | - | - | - | - | - | 0 | 0 | 0 | 0 | - | 0 | - | ||||||
| Preferred Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Preferred Stock Shares Authorized | 45 | 45 | 45 | 45 | 1 | 1 | 45 | 1 | 1 | 1 | 1 | 1 | ||||||
| Preferred Stock Shares Issued | 5 | 5 | 5 | 5 | - | - | 0 | - | - | - | - | - | ||||||
| Preferred Stock Shares Outstanding | 5 | 5 | 5 | 5 | - | - | 0 | - | - | - | - | - | ||||||
| Common Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | - | - | 0.00 | - | - | 0.00 | 0.00 | - | ||||||
| Common Stock Shares Authorized | 740 | 740 | 740 | 740 | - | - | 200 | - | - | - | - | - | ||||||
| Common Stock Shares Issued | 230 | 230 | 230 | 230 | - | - | 200 | - | - | - | - | - | ||||||
| Shares Outstanding | 230 | 230 | 230 | 230 | - | - | 200 | - | - | - | - | - | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialSemnur Pharmaceuticals, Inc. (SMNR) — SEC Financial Statements & Analysis
Semnur Pharmaceuticals, Inc. (SMNR) is a pharmaceutical preparations company, incorporated in DE. Semnur Pharmaceuticals, Inc. trades on OTC as: SMNR, SMNRW. Semnur Pharmaceuticals, Inc. (SMNR)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-10. Based on that filing, Semnur Pharmaceuticals, Inc. carries a market cap of $115.10M, a P/E ratio of -0.69x, a P/B ratio of -3.88x, an enterprise value of $117.17M, and an EV/EBITDA multiple of -0.70x. On profitability, it posts a Return on Equity (ROE) of 452.44% and a Return on Assets (ROA) of -13384.76%. Per share, it reports EPS of $-0.73, diluted EPS of $-0.73, free cash flow per share of $-0.05, and a dividend per share of $0.00. Over the trailing year, it posted net income growth of 2272.57% year-over-year and EPS growth of 1961.23% year-over-year. On the balance sheet, it maintains a current ratio of 0.11x, a quick ratio of 0.01x, working capital of $-9.48M, a debt-to-equity ratio of -1.07x, a debt ratio of 16.27, an interest coverage ratio of -1362.21x, free cash flow of $-10.54M (TTM), and net debt of $2.07M. Figures sourced from SEC EDGAR.
- Market Cap
- $115.10M
- P/E TTM
- -0.69x
- EPS TTM
- $-0.73
- P/B TTM
- -3.88x
- ROE TTM
- 452.44%
- ROA TTM
- -13384.76%
- Debt To Equity
- -1.07x
- Free Cash Flow TTM
- $-10.54M
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is Semnur Pharmaceuticals, Inc. in?
Semnur Pharmaceuticals, Inc. (SMNR) operates in the Pharmaceutical Preparations industry.
What exchange does SMNR trade on?
Semnur Pharmaceuticals, Inc. (SMNR) trades on the OTC.
Where is Semnur Pharmaceuticals, Inc. incorporated?
Semnur Pharmaceuticals, Inc. is incorporated in DE.
When was Semnur Pharmaceuticals, Inc. (SMNR)'s most recent SEC filing?
Semnur Pharmaceuticals, Inc. (SMNR)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-10.
What is SMNR's market cap?
Semnur Pharmaceuticals, Inc. (SMNR) has a market capitalization of $115.10M as of 2026-06-30.
What is SMNR's EPS (earnings per share)?
Semnur Pharmaceuticals, Inc. (SMNR)'s trailing twelve month EPS is $-0.73 as of 2026-06-30.
What is SMNR's ROE (return on equity)?
Semnur Pharmaceuticals, Inc. (SMNR)'s trailing twelve month Return on Equity (ROE) is 452.44% as of 2026-06-30.
What is SMNR's ROA (return on assets)?
Semnur Pharmaceuticals, Inc. (SMNR)'s trailing twelve month Return on Assets (ROA) is -13384.76% as of 2026-06-30.
What is SMNR's EV/EBITDA?
Semnur Pharmaceuticals, Inc. (SMNR)'s trailing twelve month EV/EBITDA is -0.70x as of 2026-06-30.